|
Press Releases
Pioneers of Targeted Breast Cancer Therapy Win Nineteenth Annual Warren Alpert Foundation Prize. BOSTON, May 30, 2007
Receptor BioLogix Names Four New Senior Executives. SOUTH SAN FRANCISCO, December 15, 2006
Receptor BioLogix Acquires Late-Stage Cancer Drug from Aphton Corp. SOUTH SAN FRANCISCO, July 31, 2006
Receptor BioLogix Names Thomas A. Glaze Chief Executive Officer. SOUTH SAN FRANCISCO, June 30, 2006
Receptor BioLogix Names Gene Burton Vice President of Process Sciences. SAN FRANCISCO, February 02, 2005
Receptor BioLogix Licenses Proprietary Technology to Incyte Corp.
SAN FRANCISCO, September 22, 2003
|
